Medpace Holdings, Inc.MEDPNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank62
3Y CAGR+85.6%
5Y CAGR-1.3%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+85.6%/yr
Quarterly compound
5Y CAGR
-1.3%/yr
Recent acceleration
Percentile
P62
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.01% |
| Q3 2025 | 25.00% |
| Q2 2025 | -16.18% |
| Q1 2025 | -0.26% |
| Q4 2024 | 21.54% |
| Q3 2024 | 9.12% |
| Q2 2024 | -14.16% |
| Q1 2024 | 30.20% |
| Q4 2023 | 10.87% |
| Q3 2023 | 15.00% |
| Q2 2023 | -14.89% |
| Q1 2023 | 6.82% |
| Q4 2022 | 3.29% |
| Q3 2022 | 40.13% |
| Q2 2022 | -13.14% |
| Q1 2022 | 25.90% |
| Q4 2021 | 2.96% |
| Q3 2021 | 21.62% |
| Q2 2021 | -8.26% |
| Q1 2021 | -14.79% |
| Q4 2020 | 22.41% |
| Q3 2020 | 70.59% |
| Q2 2020 | -15.00% |
| Q1 2020 | -2.44% |
| Q4 2019 | 22.39% |
| Q3 2019 | -11.84% |
| Q2 2019 | 40.74% |
| Q1 2019 | -15.62% |
| Q4 2018 | 18.52% |
| Q3 2018 | 17.39% |
| Q2 2018 | 12.20% |
| Q1 2018 | 32.26% |
| Q4 2017 | 24.00% |
| Q3 2017 | 4.17% |
| Q2 2017 | 14.29% |
| Q1 2017 | 42100.00% |
| Q4 2016 | -100.36% |
| Q3 2016 | -6.67% |
| Q2 2016 | 36.36% |
| Q1 2016 | 140.74% |